952675-30-8 Usage
Uses
Used in Pharmaceutical Synthesis:
3-Azetidineacetic acid hydrochloride is used as a reagent in the pharmaceutical industry for the synthesis of various pharmaceutical compounds. Its unique chemical structure and properties make it a valuable component in the development of new drugs.
Used in Chelating Applications:
As a chelating agent, 3-azetidineacetic acid hydrochloride is used to bind metal ions and form stable complexes. This application is particularly useful in various industries, such as water treatment and environmental remediation, where the removal or stabilization of metal ions is necessary.
Used in Drug Development:
3-Azetidineacetic acid hydrochloride has been studied for its potential applications in drug development due to its unique chemical structure and properties. Its ability to bind metal ions and form stable complexes can contribute to the development of new drugs with novel mechanisms of action.
Used in Materials Science:
3-AZETIDINEACETIC ACID HYDROCHLORIDE's potential applications extend to the field of materials science, where its unique properties can be harnessed to create new materials with specific characteristics, such as improved stability or reactivity.
Check Digit Verification of cas no
The CAS Registry Mumber 952675-30-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,2,6,7 and 5 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 952675-30:
(8*9)+(7*5)+(6*2)+(5*6)+(4*7)+(3*5)+(2*3)+(1*0)=198
198 % 10 = 8
So 952675-30-8 is a valid CAS Registry Number.
952675-30-8Relevant academic research and scientific papers
Pyrimidine amine compound, and preparation method and application thereof
-
Paragraph 0656-0657; 0658-0659, (2020/07/02)
The invention discloses a polycyclic compound, and a preparation method and an application thereof. The invention provides the polycyclic compound represented by formula I, or a pharmaceutically acceptable salt thereof. The compound has a relatively good inhibition effect on CDK7.
Therapeutic Compounds
-
Page/Page column 99, (2011/04/25)
Compounds of formula I or pharmaceutically acceptable salts thereof: wherein R1, R2, R3 and R4 are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.
Therapeutic Compounds
-
Page/Page column 103, (2008/06/13)
Compounds of formula I or pharmaceutically acceptable salts thereof: wherein R1, R2, R3 and R4 are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.
